Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling
出版年份 2015 全文链接
标题
Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling
作者
关键词
-
出版物
Scientific Reports
Volume 5, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-09-22
DOI
10.1038/srep14404
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pancreatic Adenocarcinoma, Version 2.2012
- (2017) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy
- (2016) Younak Choi et al. Cancer Research and Treatment
- Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells
- (2015) Ryoichi Tanaka et al. PLoS One
- Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma
- (2015) Shau-Hsuan Li et al. SURGERY
- pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression
- (2015) Min Wang et al. World Journal of Surgical Oncology
- Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer
- (2015) Igor Vujic et al. Oncotarget
- Exogenous IGFBP-2 promotes proliferation, invasion and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway
- (2014) S Han et al. BRITISH JOURNAL OF CANCER
- AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell
- (2014) Gang Han et al. CANCER BIOLOGY & THERAPY
- mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma
- (2014) Wesley K. Utomo et al. CANCER LETTERS
- Targeting mTOR dependency in pancreatic cancer
- (2014) Douglas C Morran et al. GUT
- Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer
- (2014) Vijayalekshmi Nair et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Culture Dimensionality Influences the Resistance of Glioblastoma Stem-like Cells to Multikinase Inhibitors
- (2014) G. Fernandez-Fuente et al. MOLECULAR CANCER THERAPEUTICS
- Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells
- (2014) Ming Ming et al. PLoS One
- Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells
- (2014) A. Janzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
- (2014) Altaf Mohammed et al. Translational Oncology
- Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
- (2014) Kevin M. Schuler et al. Cancer Medicine
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells
- (2013) Heloisa P. Soares et al. PLoS One
- Low Concentrations of Metformin Selectively Inhibit CD133+ Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
- (2013) Shanmiao Gou et al. PLoS One
- Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells
- (2013) Enza Lonardo et al. PLoS One
- Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
- (2013) A. M. Robitaille et al. SCIENCE
- Screening for Pancreatic Cancer
- (2012) Katherine E. Poruk et al. ANNALS OF SURGERY
- Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine
- (2012) Tomomi Hayashi et al. CANCER SCIENCE
- Metformin selectively affects human glioblastoma tumor-initiating cell viability
- (2012) Roberto Würth et al. CELL CYCLE
- Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
- (2012) N. Sadeghi et al. CLINICAL CANCER RESEARCH
- The developing cancer stem-cell model: clinical challenges and opportunities
- (2012) Louis Vermeulen et al. LANCET ONCOLOGY
- Expanding Surgical Treatment of Pancreatic Cancer
- (2012) Jeremy L. Davis et al. PANCREAS
- Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies
- (2011) Angelo Andriulli et al. ANNALS OF SURGICAL ONCOLOGY
- Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
- (2011) B. Bao et al. Cancer Prevention Research
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Ascochlorin inhibits growth factor-induced HIF-1α activation and tumor-angiogenesis through the suppression of EGFR/ERK/p70S6K signaling pathway in human cervical carcinoma cells
- (2011) Ji-Hak Jeong et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Antidiabetic Drug Metformin Induces Apoptosis in Human MCF Breast Cancer via Targeting ERK Signaling
- (2011) Ahmed Malki et al. ONCOLOGY RESEARCH
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
- (2010) Adem Kalender et al. Cell Metabolism
- Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
- (2010) E. Rozengurt et al. CLINICAL CANCER RESEARCH
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study
- (2010) Jean-Luc Van Laethem et al. JOURNAL OF CLINICAL ONCOLOGY
- Antidiabetic Therapies Affect Risk of Pancreatic Cancer
- (2009) Donghui Li et al. GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now